Cart
sales@molnova.com
Dihydropseudoionone
CAS No. 689-67-8
Dihydropseudoionone( Geranylacetone(Z/E) )
Catalog No. M21651 CAS No. 689-67-8
Dihydropseudoionone is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameDihydropseudoionone
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydropseudoionone is a chemical compound.
-
DescriptionDihydropseudoionone is a chemical compound.
-
In Vitro——
-
In Vivo——
-
SynonymsGeranylacetone(Z/E)
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number689-67-8
-
Formula Weight194.31
-
Molecular FormulaC13H22O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (514.64 mM)
-
SMILESCC(=O)CCC=C(C)CC\C=C(\C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Extensive metabolic cross-talk in melon fruit revealed by spatial and developmental combinatorial metabolomics[J]. New Phytologist 2011 190(3):683-696.
molnova catalog
related products
-
MYCOPHENOLATE SODIUM
Mycophenolic acid (sodium) (Standard) is the analytical standard of Mycophenolic acid (sodium). This product is intended for research and analytical applications. Mycophenolic acid sodium is a potent uncompetitive inosine monophosphate dehydrogenase (IMPDH) inhibitor with an EC50 of 0.24 μM. Mycophenolic acid sodium demonstrates antiviral effects against a wide range of RNA viruses including influenza. Mycophenolic acid sodium is an immunosuppressive agent. Antiangiogenic and antitumor effects.
-
AIMP2-DX2-IN-1
AIMP2-DX2-IN-1 is a potent AIMP2-DX2 inhibitor with potential antitumor activity for the study of lymphoma.
-
DTP3
DTP3 is a selective MKK7/GADD45β inhibitor, which inhibits cancer-selective NF-κB survival pathway.
